OFLOXIN

This brand name is authorized in Cyprus, Estonia, Lithuania, Romania

Active ingredients

The drug OFLOXIN contains one active pharmaceutical ingredient (API):

1 Ofloxacin UNII A4P49JAZ9H - OFLOXACIN

Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination. Read about Ofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OFLOXIN Film-coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01MA01	Ofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1089402, 1089413, 1089424
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003317, 1022490
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W56957001